SymBio Pharmaceuticals Limited【JP:4582】Cash flow
Market cap
¥4.4B
P/E ratio
-0.9x
| 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 13 | 24 | 26 | 30 | 35 | 38 | 64 | 94 | 98 | 96 | - |
| Cash from operations | -1,266 | -2,272 | -1,960 | -3,817 | -2,325 | -4,351 | -4,122 | 140 | 1,614 | -195 | -3,417 |
| Capital expenditures | -45 | -23 | -24 | -11 | -32 | -24 | -16 | -25 | -2 | -204 | -20 |
| Cash from investing | 314 | 1,489 | -44 | -78 | -26 | -216 | -160 | -71 | -47 | -377 | -4 |
| Repurchases of common stock | - | - | - | - | - | -21 | -6 | -69 | -2 | -1 | -1 |
| Cash from financing | 544 | -3 | 3,658 | 1,164 | 4,272 | 3,740 | 4,222 | -72 | 628 | 680 | 708 |